A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
Condition:   Bioequivalence Interventions:   Drug: Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use;   Drug: Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use Sponsors:   Pharmtechnology LLC;   Altasciences Company Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2019 Category: Research Source Type: clinical trials

The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Condition:   Bioequivalence Interventions:   Drug: Olmesartan Medoxomil 40 mg;   Drug: Olmetec® Sponsors:   Pharmtechnology LLC;   Altasciences Company Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2019 Category: Research Source Type: clinical trials

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions
Condition:   Healthy Subjects Interventions:   Drug: Torrent's Olmesartan Medoxomil Tablets 40 mg;   Drug: Daiichi Sankyo Inc's Benicar Tablets 40 mg Sponsor:   Torrent Pharmaceuticals Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2017 Category: Research Source Type: clinical trials

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions
Condition:   Healthy Subjects Interventions:   Drug: Torrent's Olmesartan Medoxomil Tablets 40 mg;   Drug: Daiichi Sankyo Inc's Benicar Tablets 40 mg Sponsor:   Torrent Pharmaceuticals Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2017 Category: Research Source Type: clinical trials